4.8 Review

Innate lymphoid cells: A new paradigm in immunology

Journal

SCIENCE
Volume 348, Issue 6237, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aaa6566

Keywords

-

Funding

  1. Medical Research Council [MC_U105178805] Funding Source: Medline
  2. NCI NIH HHS [R21 CA167192, R21CA16719] Funding Source: Medline
  3. NIAID NIH HHS [1U01AI095542, U01 AI095542] Funding Source: Medline
  4. NIDCR NIH HHS [R01 DE021255, R01DE021255] Funding Source: Medline
  5. Wellcome Trust [100963] Funding Source: Medline
  6. Medical Research Council [MC_U105178805] Funding Source: researchfish
  7. Wellcome Trust [100963/Z/13/Z] Funding Source: researchfish
  8. MRC [MC_U105178805] Funding Source: UKRI

Ask authors/readers for more resources

Innate lymphoid cells (ILCs) are a growing family of immune cells that mirror the phenotypes and functions of T cells. However, in contrast to T cells, ILCs do not express acquired antigen receptors or undergo clonal selection and expansion when stimulated. Instead, ILCs react promptly to signals from infected or injured tissues and produce an array of secreted proteins termed cytokines that direct the developing immune response into one that is adapted to the original insult. The complex cross-talk between microenvironment, ILCs, and adaptive immunity remains to be fully deciphered. Only by understanding these complex regulatory networks can the power of ILCs be controlled or unleashed in order to regulate or enhance immune responses in disease prevention and therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available